If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrellus Health. Regulatory News (TRLS)

  • This share is currently suspended. It was suspended at a price of 0.12

Share Price Information for Trellus Health. (TRLS)

Share Price is delayed by 15 minutes
Get Live Data
0.12    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £516.14k
TRLS Live PriceLast checked at - London Stock Exchange

Intraday Trellus Health. Share Chart

Trellus Health

Today 18:00

RNS Number : 2139L
FTSE Russell
06 July 2026
 

 

 

Suspended Company Notice - Deletion

06 July 2026

Further to the notice released on 08 June 2026, the following company has been suspended 40 business days without

indication of resumption. In accordance with the Suspension of Dealing rule, it will be removed from the FTSE Russell

index for the open of 09 July 2026 at nominal value (0.0001).

 

· Trellus Health (BNNFM40, FTSE AIM All-Share Index)

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Asia Pacific ex Japan

+852 2164 3333

Japan

+81 3 6441 1430

Europe, Middle East & Africa

+44 (0) 20 7866 1810

North America

+1 800 721 2225

Alternatively, please visit our website at lseg.com/ftse-russell

Terms of Use | Copyright © 2026 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSBUGDRGXGDGLL
Date   Source Headline
6th Jul 20266:00 pmRNSTrellus Health
30th Jun 20266:30 pmRNSDelay to Publication of Annual Report and Accounts
19th Jun 20267:00 amRNSUpdate
8th May 20267:30 amRNSSuspension - Trellus Health Plc
8th May 20267:00 amRNSUpdate on Funding & Suspension of Trading
28th Apr 20267:00 amRNSIssue of Equity - Conversion of Loan Notes
15th Apr 20267:00 amRNSIssue of Equity - Conversion of Loan Notes
13th Apr 20267:00 amRNSPfizer Licensing Agreement Renewal
8th Apr 20267:00 amRNSIssue of Equity - Conversion of Loan Notes
2nd Apr 20267:00 amRNSFunding Update
27th Mar 20267:00 amRNSMSA Signed and Funding Update
18th Mar 202612:29 pmRNSIssue of Equity - Conversion of Loan Notes
13th Mar 20268:45 amRNSHolding(s) in Company
13th Mar 20268:45 amRNSHolding(s) in Company
13th Mar 20268:43 amRNSHolding(s) in Company
13th Mar 20268:43 amRNSHolding(s) in Company
10th Mar 20267:01 amRNSHolding(s) in Company
10th Mar 20267:01 amRNSHolding(s) in Company
10th Mar 20267:00 amRNSIssue of Equity - Conversion of Loan Notes
2nd Mar 20267:00 amRNSIssue of Equity - Conversion of Loan Notes
26th Feb 20263:08 pmRNSHolding(s) in Company
23rd Feb 20267:00 amRNSIssue of Equity
18th Feb 20267:05 amRNSContract Extension with Johnson & Johnson
18th Feb 20267:00 amRNSIssue of Equity - Conversion of Loan Notes
11th Feb 20267:00 amRNSIssue of Equity
6th Feb 202610:45 amRNSHolding(s) in Company
3rd Feb 20265:37 pmRNSHolding(s) in Company
3rd Feb 20265:31 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSBusiness update
29th Jan 20267:00 amRNSGrant of Share Options
22nd Jan 20267:00 amRNSHolding(s) in Company
20th Jan 20262:00 pmRNSResult of Meeting
19th Jan 20267:00 amRNSGrant of Share Options
30th Dec 20255:00 pmRNSProposed issue of Secured Convertible Loan Notes
30th Dec 20255:00 pmRNSProposed issue of Secured Convertible Loan Notes
24th Nov 20257:00 amRNSFinance update
7th Nov 20257:00 amRNSContract signed with second leading CRO
22nd Oct 20257:00 amRNSContract Signed with Leading Global CRO
21st Oct 20257:00 amRNSCompany Update
8th Sep 20253:15 pmRNSInterim results - Replacement
8th Sep 20257:00 amRNSInterim results
3rd Sep 20257:00 amRNSNotice of Results
12th Aug 20257:00 amRNSHolding(s) in Company
1st Jul 20257:00 amRNSResult of AGM
30th Jun 20257:00 amRNSAGM Statement
4th Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20257:00 amRNSFinal Results
23rd Apr 20254:30 pmRNSGrant of Share Options
4th Mar 20257:00 amRNSBusiness update
14th Jan 20257:00 amRNSAgreement with Johnson & Johnson

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.